We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
-22.42%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$1.6B
AUM Growth
-$352M
Cap. Flow
+$184M
Cap. Flow %
11.49%
Top 10 Hldgs %
58.81%
Holding
50
New
7
Increased
5
Reduced
7
Closed
2

Top Sells

Rank Stock Value
1
OVV icon
Ovintiv
OVV
+$50.6M
2
LNG icon
Cheniere Energy
LNG
+$50.5M
3
EXE
Expand Energy Corp
EXE
+$47M
4
NOV icon
NOV
NOV
+$11.8M
5
RIG icon
Transocean
RIG
+$10.9M

Sector Composition

Rank Sector Weight
1 Energy 32.7%
2 Communication Services 23.22%
3 Materials 12.61%
4 Real Estate 7.39%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
26
Invivyd
IVVD
$158M
$12.3M 0.77%
3,735,000
PDCE
27
DELISTED
PDC Energy, Inc.
PDCE
$10.5M 0.65%
+170,000
New +$12.3M
GLHAU
28
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
$9.8M 0.61%
1,000,000
PAGS icon
29
PagSeguro Digital
PAGS
$2.69B
$7.99M 0.5%
780,000
-745,000
-49% -$10.7M
CLF icon
30
Cleveland-Cliffs
CLF
$6.57B
$7.45M 0.47%
485,000
RIVN icon
31
Rivian
RIVN
$22B
$6.18M 0.39%
+240,000
New +$7.5M
BLUA.U
32
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
$5.91M 0.37%
600,000
FVAM
33
DELISTED
5:01 Acquisition Corp
FVAM
$4.95M 0.31%
500,000
PHICU
34
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$4.95M 0.31%
500,000
CYCN icon
35
Cyclerion Therapeutics
CYCN
$14.9M
$3.93M 0.25%
357,880
CUE icon
36
Cue Biopharma
CUE
$113M
$3.69M 0.23%
49,454
EIGR
37
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.61M 0.1%
8,500
NEXI
38
DELISTED
NexImmune, Inc. Common Stock
NEXI
$1.49M 0.09%
37,000
VAL icon
39
Valaris
VAL
$5.48B
$1.23M 0.08%
+29,000
New +$1.56M
PLG
40
Platinum Group Metals
PLG
$164M
$1.19M 0.07%
+900,000
New +$1.55M
KGC icon
41
Kinross Gold
KGC
$27.4B
$644K 0.04%
180,000
IAG icon
42
IAMGOLD
IAG
$8.2B
$564K 0.04%
350,000
RNLX
43
DELISTED
Renalytix plc American Depositary Shares
RNLX
$429K 0.03%
175,214
AUROW
44
Aurora Innovation Warrant
AUROW
$352M
$175K 0.01%
437,500
BHIL.WS
45
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$118K 0.01%
250,000
HIPO.WS
46
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$67K ﹤0.01%
350,000
LMACW
47
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$50K ﹤0.01%
100,000
BRDS.WS
48
DELISTED
Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share
BRDS.WS
$7K ﹤0.01%
120,000
OVV icon
49
Ovintiv
OVV
$17.3B
-935,000
Closed -$50.6M
STNE icon
50
StoneCo
STNE
$2.77B
-745,000
Closed -$8.72M

Similar funds

Slate Path Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Slate Path Capital held 50 positions worth $1.6B, down 18% from $1.95B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Slate Path Capital deployed $184M of net new capital in Q2 2022, opening 7 new positions and adding to 5 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,600,000 shares worth $126M.

By sector, the portfolio is most concentrated in Energy at 33% of assets, down from 37% a quarter earlier, followed by Communication Services and Materials.

On the sell side, the largest reduction was Cheniere Energy, an estimated $50.5M trimmed.

  • Slate Path Capital's largest Q2 2022 buy was VanEck Gold Miners ETF: 4,600,000 shares worth $126M.
  • Slate Path Capital added most to VanEck Junior Gold Miners ETF in Q2 2022, an estimated $35M increase.
  • Slate Path Capital's biggest Q2 2022 reduction was Cheniere Energy, cutting an estimated $50.5M.
  • Slate Path Capital fully exited Ovintiv in Q2 2022, selling an estimated $50.6M.
  • Slate Path Capital's ten largest holdings make up 59% of its $1.6B portfolio in Q2 2022.
  • Slate Path Capital opened 7 new positions and closed 2 in Q2 2022.
  • Slate Path Capital's portfolio value fell 18% quarter-over-quarter to $1.6B.

Based on Slate Path Capital's 13F filing for Q2 2022, filed 15 Aug 2022.